- Stocks
- Pharma & Healthcare
- Vaishali Pharma
Vaishali Pharma share price
NSE: VAISHALIPharma & HealthcareDrug Manufacturers - Specialty & Generic
Vaishali Pharma at a glance
Vaishali Pharma (NSE: VAISHALI) closed at ₹7.49 on 22 Oct 2026, up 2.04% on the day. With a market capitalisation of ₹101 Cr, it ranks 2673rd by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Drug Manufacturers - Specialty & Generic.
At its last close the stock traded at 124.8× trailing earnings, against a return on equity of 1.3% in FY25. Over the past year the share price has fallen 30.3%. Its 52-week range is ₹4.75 (30 Mar 2026) to ₹11.15 (28 Oct 2025); the last close is 32.8% below the high. Promoters held 30.54% of the company as of 3 Jul 2026.
Key numbers
- Market cap
- ₹101 CrRank 2673 on NSE
- P/E (trailing)
- 124.8×
- Price to book
- 2.53×FY25
- ROE
- 1.3%FY25
- ROCE
- 4.0%FY25
- Debt to equity
- 0.18FY25
- Net profit margin
- 0.8%FY25
- Book value / share
- ₹4.98FY25
- 52-week high
- ₹11.1528 Oct 2025
- 52-week low
- ₹4.7530 Mar 2026
- 1-year return
- −30.3%
- RSI (14-day)
- 36.1
Returns to 22 Oct 2026
| Period | 1 day | 1 week | 1 month | 3 months | 1 year |
|---|---|---|---|---|---|
| Price change | +2.04% | −5.0% | −10.3% | −5.2% | −30.3% |
Vaishali Pharma financials
| Item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Revenue | ₹60 Cr | ₹54 Cr | ₹76 Cr | ₹70 Cr | ₹86 Cr | ₹99 Cr |
| Operating profit | ₹0 Cr | ₹1 Cr | ₹6 Cr | ₹9 Cr | ₹1 Cr | ₹1 Cr |
| Net profit | ₹0 Cr | ₹1 Cr | ₹4 Cr | ₹7 Cr | ₹1 Cr | ₹1 Cr |
| EPS (₹) | ₹0.03 | ₹0.99 | ₹3.82 | ₹6.26 | ₹0.68 | ₹0.06 |
| Cash from operations | ₹3 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | −₹18 Cr |
| Total debt | ₹4 Cr | ₹4 Cr | ₹3 Cr | ₹5 Cr | ₹4 Cr | ₹4 Cr |
| Shareholders' equity | ₹21 Cr | ₹22 Cr | ₹26 Cr | ₹33 Cr | ₹36 Cr | ₹65 Cr |
Vaishali Pharma shareholding pattern
| Holder | 30 Sep 2025 | 24 Dec 2025 | 31 Dec 2025 | 31 Mar 2026 | 30 Jun 2026 | 3 Jul 2026 |
|---|---|---|---|---|---|---|
| Promoters | 26.32% | 31.61% | 31.61% | 31.61% | 31.61% | 30.54% |
| Non-institutions | 73.68% | 68.39% | 68.39% | 68.39% | 68.39% | 69.46% |
Vaishali Pharma vs peers
The listed Pharma & Healthcare companies nearest to Vaishali Pharma by market capitalisation.
| Company | Price | 1 day | 1 year | Market cap | P/E | ROE |
|---|---|---|---|---|---|---|
| MERCURYLABMercury Labs | — | — | — | ₹102 Cr | — | — |
| VAISHALIVaishali Pharma | ₹7.49 | +2.04% | −30.3% | ₹101 Cr | 124.8 | — |
| CONCORDConcord Drugs | — | — | — | ₹101 Cr | — | — |
| DENISCHEMDenis Chem Lab | — | — | — | ₹101 Cr | — | — |
| FORTISMLRFortis Malar | — | — | — | ₹97 Cr | — | — |
| RAAJMEDIRaaj Medisafe | — | — | — | ₹97 Cr | — | — |
| KHFMKHFM HOSPITALIT | ₹40.90 | +4.87% | −50.1% | ₹95 Cr | — | — |
Ask anything about Vaishali Pharma
Pivot answers on the live chart with evidence you can check, and tests strategies against VAISHALI's own history. Try: “Why has VAISHALI moved over the last three months?” · “Backtest a 50-day moving-average crossover on VAISHALI over five years” · “Compare VAISHALI with MERCURYLAB on margins and valuation”
Frequently asked questions about Vaishali Pharma
What is the share price of Vaishali Pharma today?
Vaishali Pharma (NSE: VAISHALI) last closed at ₹7.49 on 22 Oct 2026. Its 52-week high is ₹11.15 and its 52-week low is ₹4.75.
What is the market cap of Vaishali Pharma?
Vaishali Pharma's market capitalisation is ₹101 Cr (₹101 Cr) at the 22 Oct 2026 close, ranking 2673rd among the NSE companies Pivot tracks.
What is the P/E ratio of Vaishali Pharma?
Vaishali Pharma trades at a trailing P/E of 124.8.
What is the ROE and ROCE of Vaishali Pharma?
Return on equity was 1.3% in FY25 and return on capital employed was 4.0% in FY25 (standalone figures).
Is Vaishali Pharma a debt-free company?
No. Vaishali Pharma's debt-to-equity ratio was 0.18 in FY25, with total debt of ₹4 Cr.
How has Vaishali Pharma stock performed over the last year?
Vaishali Pharma's share price has fallen 30.3% over the past year, −5.2% over three months and −10.3% over one month, to the 22 Oct 2026 close.
What is the shareholding pattern of Vaishali Pharma?
As of 3 Jul 2026: promoters 30.54%, non-institutions 69.46%.
Who are Vaishali Pharma's competitors?
The listed Pharma & Healthcare companies closest to Vaishali Pharma by market cap are Mercury Labs, Concord Drugs, Denis Chem Lab, Fortis Malar, Raaj Medisafe and KHFM HOSPITALIT.
Is Vaishali Pharma a good stock to buy?
Pivot does not give buy or sell recommendations. This page sets out Vaishali Pharma's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on VAISHALI against its own history before risking money. This is analysis, not financial advice.
Sources and method
Prices: NSE daily closes to 22 Oct 2026 (returns and ratios at the 22 Oct 2026 close). Fundamentals: company filings via Moneycontrol, consolidated where available. Shareholding: exchange shareholding-pattern filings. The 52-week range uses intraday highs and lows; the chart marks closing prices. P/E is the last close over trailing twelve-month EPS. Market-cap rank is among the 4,183 NSE companies Pivot tracks; SEBI's bands call the top 100 large-cap and the next 150 mid-cap. Figures marked “—” are not available rather than zero. This is analysis, not financial advice.
More: all Pharma & Healthcare stocks · companies starting with V · all NSE stocks · this page as text